Repligen
RGEN
#2045
Rank
NZ$16.07 B
Marketcap
NZ$285.58
Share price
-0.47%
Change (1 day)
18.08%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of September 2025 : NZ$1.29 Billion

According to Repligen 's latest financial reports the company has NZ$1.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$1.34 B13.03%
2023-12-31NZ$1.18 B20.93%
2022-12-31NZ$0.98 B11.14%
2021-12-31NZ$0.88 B-11.08%
2020-12-31NZ$0.99 B26.71%
2019-12-31NZ$0.78 B171.52%
2018-12-31NZ$0.28 B18.1%
2017-12-31NZ$0.24 B19.53%
2016-12-31NZ$0.20 B95.18%
2015-12-31NZ$0.10 B40.57%
2014-12-31NZ$74.6 M-0.51%
2013-12-31NZ$74.98 M54.01%
2012-12-31NZ$48.69 M
2011-03-31NZ$65.23 M-13.1%
2010-03-31NZ$75.07 M-12.88%
2009-03-31NZ$86.17 M39.16%
2008-03-31NZ$61.92 M95.82%
2007-03-31NZ$31.62 M1.39%
2006-03-31NZ$31.18 M28.92%
2005-03-31NZ$24.19 M15.72%
2004-03-31NZ$20.9 M-25.44%
2003-03-31NZ$28.03 M-40.7%
2002-03-31NZ$47.28 M-21.55%
2001-03-31NZ$60.27 M-12.37%
2000-03-31NZ$68.78 M1015.16%
1999-03-31NZ$6.16 M-27.5%
1998-03-31NZ$8.5 M68.88%
1997-03-31NZ$5.03 M-49.98%
1996-03-31NZ$10.07 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novavax
NVAX
NZ$1.32 B 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.55 B 97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.92 B 48.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$23.38 B 1,704.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$6.13 B 373.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$28.56 B 2,103.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$25.93 B 1,901.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.25 B-80.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$51.26 M-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$0.35 B-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA